April 11, 2025 09:18 AM EDT
FDA+
Manufacturing

CD­MOs an­tic­i­pate in­spec­tion bot­tle­necks af­ter mass FDA fir­ings

Anna Brown

News Reporter

CD­MOs fear that FDA site in­spec­tions might slow down due to the mass staffing cuts at the fed­er­al health agen­cies.

While Pres­i­dent Don­ald Trump’s po­ten­tial …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mar­ket tur­moil is tank­ing biotech M&A and IPOs. Here's the play­book star­tups will use to sur­vive

Makary wants to re­place an­i­mal test­ing with organoids. It may take a while

Re­cruiters say some bio­phar­mas pause hir­ing as they strug­gle to make sense of on­go­ing un­cer­tain­ty

Ex­clu­sive: Meri­da Bio­sciences gets $121M to treat au­toim­mune and al­ler­gy dis­eases at their roots

Bris­tol My­er­s' im­munother­a­py com­bo nets ap­provals in col­orec­tal and liv­er can­cer

Phar­ma tar­iffs: Here’s what a po­ten­tial roll­out could look like

A service from the Financial Times